Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Decreased Temperature Associated with Increased ED Visits By Patients with Sickle Cell Disease

Jessica Lander, MD MPH, Tanisha Jones, MSN, APN, F-NP, Gabrielle Lapping-Carr, MD, Radhika Peddinti, MD, Wendy S Darlington, MD MAPP

Blood (2018) 132 (Supplement 1): 2385.

https://doi.org/10.1182/blood-2018-99-115517

Published: 2018

Journal Articles

Telehematology: Expanding Comprehensive Care for Pediatric Patients with Blood Disorders through Telemedicine at Several Delivery Sites (Medical Homes, Hospital Clinics, Home Setting and Hemophilia Treatment Centers (HTC)) and with Interdisciplinary Providers

Roshni Kulkarni, Laura Carlson, RN, Rebecca A Malouin, Ph. D.,M.S, M.P.H, Marcia L Bird, LMSW, Colleen Vallad-Hix, Michelle Witkop, DNP, FNP-BC, Ajovi Scott-Emuakpor, MDPhD, Renuka Gera, MD, Steve Gualdoni, PA

Blood (2015) 126 (23): 5576.

https://doi.org/10.1182/blood.V126.23.5576.5576

Published: 2015

Journal Articles

A Survey of Resident Physicians' and Nurses' Knowledge of Severity Assessment of Acute Chest Syndrome and Role of Incentive Spirometry in Management

Nupur Mittal, MD, Lewis L. Hsu, MD PhD

Blood (2015) 126 (23): 2064.

https://doi.org/10.1182/blood.V126.23.2064.2064

Published: 2015

Journal Articles

Manual Erythro-Exchange (MEEX) to Prevent Complications of Sickle Cell Disease in Patients Unresponsive to Hydroxyurea: A Long-Term Follow-up

Gianluca Forni, MD, Manuela Balocco, Laura Terenzani, Paola Carrara

Blood (2008) 112 (11): 4815.

https://doi.org/10.1182/blood.V112.11.4815.4815

Published: 2008

Journal Articles

Letter to authors and readers regarding the new NIH policy on public access

James N. George, MD, Sanford J. Shattil, MD

Blood (2005) 105 (10): 3767.

https://doi.org/10.1182/blood-2005-04-1396

Published: 2005

Journal Articles

FDA Policies Should Be Amended To Allow Pharmaceutical Manufacturers To Disseminate Information Regarding Potentially Fatal Toxicities That Occur with Off-Label Use of Oncology Agents: A Policy Recommendation Based on Review of Thalidomide-Associated Thromboembolism Cases by the RADAR Project.

Andrew M. Evens, DO, Martin S. Tallman, MD, Seema Singhal, MD, June M. McKoy, MD, JD, E. Allison Lyons, BA, Dennis W. Raisch, PhD, Paul R. Yarnold, PhD, Hau Kwaan, MD, Timothy M. Kuzel, MD, Jayesh Mehta, MD, Charles L. Bennett, MD, PhD

Blood (2004) 104 (11): 265.

https://doi.org/10.1182/blood.V104.11.265.265

Published: 2004

NARROW

Decreased Temperature Associated with Increased ED Visits By Patients with Sickle Cell Disease

Telehematology: Expanding Comprehensive Care for Pediatric Patients with Blood Disorders through Telemedicine at Several Delivery Sites (Medical Homes, Hospital Clinics, Home Setting and Hemophilia Treatment Centers (HTC)) and with Interdisciplinary Providers

A Survey of Resident Physicians' and Nurses' Knowledge of Severity Assessment of Acute Chest Syndrome and Role of Incentive Spirometry in Management

Manual Erythro-Exchange (MEEX) to Prevent Complications of Sickle Cell Disease in Patients Unresponsive to Hydroxyurea: A Long-Term Follow-up

Letter to authors and readers regarding the new NIH policy on public access

FDA Policies Should Be Amended To Allow Pharmaceutical Manufacturers To Disseminate Information Regarding Potentially Fatal Toxicities That Occur with Off-Label Use of Oncology Agents: A Policy Recommendation Based on Review of Thalidomide-Associated Thromboembolism Cases by the RADAR Project.

Email alerts

ASH Publications

American Society of Hematology

Decreased Temperature Associated with Increased ED Visits By Patients with Sickle Cell Disease

Telehematology: Expanding Comprehensive Care for Pediatric Patients with Blood Disorders through Telemedicine at Several Delivery Sites (Medical Homes, Hospital Clinics, Home Setting and Hemophilia Treatment Centers (HTC)) and with Interdisciplinary Providers

A Survey of Resident Physicians' and Nurses' Knowledge of Severity Assessment of Acute Chest Syndrome and Role of Incentive Spirometry in Management

Manual Erythro-Exchange (MEEX) to Prevent Complications of Sickle Cell Disease in Patients Unresponsive to Hydroxyurea: A Long-Term Follow-up

Letter to authors and readers regarding the new NIH policy on public access

FDA Policies Should Be Amended To Allow Pharmaceutical Manufacturers To Disseminate Information Regarding Potentially Fatal Toxicities That Occur with Off-Label Use of Oncology Agents: A Policy Recommendation Based on Review of Thalidomide-Associated Thromboembolism Cases by the RADAR Project.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only